Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults

paythelady.612 shared this article with you from Inoreader Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults Μέσω pubmed: "world j clin cases"... World J Clin Cases. 2021 Jun 26;9(18):4491-4499. doi: 10.12998/wjcc.v9.i18.4491. ABSTRACT Hepatitis C virus (HCV)/human immunodeficiency virus (HIV) coinfection is a major problem among HIV-infected patients, resulting in increased morbidity and mortality rates due to the acceleration of liver fibrosis progression by HIV, leading to liver cirrhosis and hepatocellular carcinoma. Although the efficacy of direct-acting antiviral therapy in patients with HIV/HCV coinfection and HCV monoinfection are similar in terms of sustained virologic response rate, there are some additional complications that arise in the treatment of patients with HIV/HCV coinfection, including drug-drug interactions and HCV reinfection due to the high risk behavior of these patients. This review will summarize the current management of HIV/HCV coinfection. PMID:34222417 | PMC:PMC8223861 | DOI:10.12998/wjcc.v9.i18.4491 View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.